Northwestern University Human Resources
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1851-01-28
- Employees
- 5K
- Market Cap
- -
Doxorubicin Hydrochloride Liposome and Rituximab With Combination Chemotherapy in Treating Patients With Newly Diagnosed Burkitt's Lymphoma or Burkitt-Like Lymphoma
- Conditions
- Lymphoma
- Interventions
- Drug: Regimen ADrug: Regimen B
- First Posted Date
- 2006-10-26
- Last Posted Date
- 2019-10-15
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 25
- Registration Number
- NCT00392990
- Locations
- 🇺🇸
Loyola University Medical Center, Maywood, Illinois, United States
🇺🇸University Hospitals Case Medical Center, Cleveland, Ohio, United States
🇺🇸Washington University, Saint Louis, Missouri, United States
Neuraxial Versus Systemic Analgesia for Latent Phase Labor Effect on Rate of Operative Delivery
- Conditions
- PregnancyLabor Pain
- Interventions
- Procedure: combined spinal epidural analgesiaProcedure: late analgesia (systemic)
- First Posted Date
- 2006-09-27
- Last Posted Date
- 2014-04-14
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 1026
- Registration Number
- NCT00380978
- Locations
- 🇺🇸
Northwestern Memorial Hospital, Chicago, Illinois, United States
Effect of the Subconscious on Mohs Micrographic Surgery
- Conditions
- Basal Cell CarcinomaSquamous Cell Carcinoma
- Interventions
- Behavioral: relaxation therapy 3Behavioral: relaxation therapy 1Behavioral: relaxation therapy 2
- First Posted Date
- 2006-09-08
- Last Posted Date
- 2014-07-15
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 150
- Registration Number
- NCT00374062
- Locations
- 🇺🇸
Murad Alam, MD, Chicago, Illinois, United States
Phase I/II Trial of VELCADE Plus Zevalin in Patients With Relapsed or Refractory Follicular Lymphoma
- Conditions
- Lymphoma
- Interventions
- First Posted Date
- 2006-09-07
- Last Posted Date
- 2019-09-04
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 18
- Registration Number
- NCT00372905
- Locations
- 🇺🇸
Northwestern University, Chicago, Illinois, United States
🇺🇸Emory University School of Medicine, Atlanta, Georgia, United States
Gemcitabine and Pemetrexed Disodium in Treating Patients With Advanced Mycosis Fungoides or Sézary Syndrome
- First Posted Date
- 2006-08-29
- Last Posted Date
- 2019-08-28
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 14
- Registration Number
- NCT00369629
- Locations
- 🇺🇸
Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago, Illinois, United States
Trial of VELCADE and Rituxan as Front-line Tx for Low-grade NHL
- First Posted Date
- 2006-08-29
- Last Posted Date
- 2019-09-06
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 42
- Registration Number
- NCT00369707
- Locations
- 🇺🇸
University of Miami Sylvester Comprehensive Cancer Center - Miami, Miami, Florida, United States
🇺🇸Hematology-Oncology Associates of Illinois, Chicago, Illinois, United States
🇺🇸Northwestern University, Chicago, Illinois, United States
Effects of Topical Vitamin K, Vitamin K and Retinol, and Arnica on Post-Laser Bruising
- Conditions
- Ecchymosis
- Interventions
- First Posted Date
- 2006-08-15
- Last Posted Date
- 2021-12-03
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 16
- Registration Number
- NCT00363038
- Locations
- 🇺🇸
Northwestern University Feinberg School of Medicine, Department of Dermatology, Chicago, Illinois, United States
Midlife Cholesterol Study
- Conditions
- MenopausePostmenopausePremenopauseCardiovascular Disease
- First Posted Date
- 2006-08-07
- Last Posted Date
- 2014-11-05
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 120
- Registration Number
- NCT00361075
- Locations
- 🇺🇸
Northwestern University, Chicago, Illinois, United States
🇺🇸University of Washington, Seattle, Washington, United States
Vatalanib in Treating Patients With Recurrent or Progressive Meningioma
- Conditions
- Brain and Central Nervous System TumorsSarcoma
- Interventions
- First Posted Date
- 2006-07-06
- Last Posted Date
- 2018-10-26
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 25
- Registration Number
- NCT00348790
- Locations
- 🇺🇸
Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago, Illinois, United States
🇺🇸Hematology-Oncology Associates of Illinois, Chicago, Illinois, United States
🇺🇸University Cancer Center at University of Washington Medical Center, Seattle, Washington, United States
Conversion of Hyperglycemic Patients Being Treated With Intravenous Insulin Infusions to Lantus Insulin
- First Posted Date
- 2006-06-20
- Last Posted Date
- 2009-04-06
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 75
- Registration Number
- NCT00338104
- Locations
- 🇺🇸
Northwestern Memorial Hospital, Chicago, Illinois, United States